Neuronetics (STIM) Tops Q3 EPS by 15c; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q3 EPS of ($0.28), $0.15 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $15.02 million.

GUIDANCE:

Neuronetics sees FY2022 revenue of $63-64 million, versus the consensus of $61.794 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance